Top

Published in:

01-02-2007 | Original Research Article

Retrospective Evaluation of Adverse Drug Reactions Induced by Nonsteroidal Anti-Inflammatory Drugs

Authors: Dr L. Gallelli, M. Colosimo, D. Pirritano, M. Ferraro, S. De Fazio, N. M. Marigliano, G. De Sarro

Published in: Clinical Drug Investigation | Issue 2/2007

Abstract

Background and objective: Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most widely prescribed drugs, and their use can be complicated by the development of adverse drug reactions (ADRs). The aim of this study was to assess the frequency of NSAID-induced ADRs in hospitalised patients in the Clinical Divisions of the Catanzaro and Cosenza hospitals.

Methods: We retrospectively analysed NSAID-induced ADRs after evaluating all ADRs recorded by the Clinical Divisions of the Catanzaro and Cosenza hospitals over a 10-year period, from January 1995 to December 2004.

Results: NSAIDs were found to be responsible for 55.2% of the episodes of ADRs overall. Diclofenac and aspirin (acetylsalicylic acid) were the drugs most frequently involved in the development of ADRs, while the skin was the body system most susceptible to NSAID-induced ADRs (43%). We determined that the drug-ADR relationship was probable in 62% of the reports; withdrawal of NSAID therapy led to a resolution of the clinical features of ADRs in 86% of episodes.

Conclusion: NSAID therapy represents a common cause of ADRs in hospitalised patients. Their use should be carefully considered, especially in the presence of polydrug therapy.

Abramson SB, Weissman G. The mechanism of action of NSAID. Arthritis Rheum 1989; 32: 1–9PubMedCrossRef

Brooks P. Use and benefits of NSAIDs. Am J Med 1998; 104: 9S–13SPubMedCrossRef

Clements PJ, Paulus HE. Nonsteroidal anti-inflammatory drugs (NSAIDs). In: Kelley WN, Harris ED, Ruddy S, et al., editors. Textbook of rheumatology, 4th ed. Philadelphia: WB Saunders Co., 1993; 700–30

Frölich JC. A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes. Trends Pharmacol Sci 1997; 18: 30–4PubMedCrossRef

Warner TD, Giuliano F, Vojnovic I, et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A 1999; 96: 7563–8PubMedCrossRef

International drug monitoring. The role of the hospital. World Health Organ Tech Rep Ser 1969; 425: 5–24

Rawlins MD. Spontaneous reporting of adverse drug reactions: I. The data. Br J Clin Pharmacol 1988; 26: 7–11PubMedCrossRef

Brewer T, Colditz GA. Postmarketing surveillance and adverse drug reactions. JAMA 1999; 281: 824–9PubMedCrossRef

Novotny J, Novotny M. Adverse drug reactions to antibiotics and major antibiotic drug interactions. Gen Physiol Biophys 1999; 18: 126–39PubMed

10.

Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2): 239–45PubMedCrossRef

11.

Karch FE, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 1977; 21: 247–54PubMed

12.

Colt HG, Shapiro AP. Drug-induced illness as a cause for admission to a community hospital. J Am Geriatr Soc 1989; 37: 323–6PubMed

13.

Carbonin P, Pahor M, Bernabei R, et al. Is age an independent risk factor of adverse drug reactions in hospitalised medical patients? J Am Geriatr Soc 1991; 39: 1093–9PubMed

14.

Hallas J, Harvald B, Gram LF, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990; 228: 83–90PubMedCrossRef

15.

Gallelli L, Ferreri G, Colosimo M, et al. Adverse drug reactions to antibiotics observed in two pulmonology divisions of Catanzaro, Italy: a six-year retrospective study. Pharmacol Res 2002; 46: 395–400PubMedCrossRef

16.

Gallelli L, Ferreri G, Colosimo M, et al. Retrospective analysis of adverse drug reactions to bronchodilators observed in two pulmonary divisions of Catanzaro, Italy. Pharmacol Res 2003; 47: 493–9PubMedCrossRef

17.

Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of non-steroidal antiinflammatory drugs. N Engl J Med 1999; 340: 1888–99PubMedCrossRef

18.

Mannesse CK, Derkx FH, de Ridder MA, et al. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000; 29: 35–9PubMedCrossRef

19.

Gallelli L, Nardi M, Prantera T, et al. Retrospective analysis of adverse drug reactions induced by gemcitabine treatment in patients with non-small cell lung cancer. Pharmacol Res 2004; 49: 259–63PubMedCrossRef

20.

Hajjar ER, Hanlon JT, Artz MB, et al. Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother 2003; 1: 82–9PubMedCrossRef

21.

Beyth RJ, Shorr RI. Epidemiology of adverse drug reactions in the elderly by drug class. Drugs Aging 1999; 14: 231–9PubMedCrossRef

22.

Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev 2001; 53: 357–79PubMed

23.

Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol 2001; 137: 765–70PubMed

24.

Smith CC, Bennett PM, Pearce HM, et al. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicine. Br J Clin Pharmacol 1996; 42: 423–9PubMedCrossRef

25.

Gallelli L, Ferraro M, Mauro GF, et al. Nimesulide-induced hepatotoxicity in a previously healthy woman. Clin Drug Invest 2005; 25: 421–4CrossRef

26.

Morwood K, Gillis D, Smith W, et al. Aspirin-sensitive asthma. Intern Med J 2005; 35: 240–6PubMedCrossRef

27.

Simon RA, Namazy J. Adverse reactions to aspirin and nonsteroidal antiinflammatory drugs (NSAIDs). Clin Rev Allergy Immunol 2003; 24: 239–52PubMedCrossRef

28.

Hamad AM, Sutcliffe AM, Knox AJ. Aspirin-induced asthma: clinical aspects, pathogenesis and management. Drugs 2004; 64: 2 17-32

29.

Schoenfeld P, Kimmey MB, Scheiman J, et al. Review article: nonsteroidal anti-inflammatory drug-associated gastrointestinal complications: guidelines for prevention and treatment. Aliment Pharmacol Ther 1999; 13: 1273–85PubMedCrossRef

30.

Fitzerald GA. Coxibs and cardiovascular disease. N Engl J Med 2004; 351: 1709–11CrossRef

31.

Martinez C, Blanco G, Ladero JM, et al. Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use. Br J Pharmacol 2004; 141: 205–8PubMedCrossRef

32.

FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001; 345: 433–42PubMedCrossRef

33.

Garattini S, Bertele V. Discontinuation of Vioxx. Lancet 2005; 365: 24

34.

Topol EJ. Arthritis medicines and cardiovascular events —“House of coxibs”. JAMA 2005; 293: 366–8PubMedCrossRef

35.

Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib. Ann Allergy Asthma Immunol 2005; 94: 34–8PubMedCrossRef

Title: Retrospective Evaluation of Adverse Drug Reactions Induced by Nonsteroidal Anti-Inflammatory Drugs
Authors: Dr L. Gallelli
M. Colosimo
D. Pirritano
M. Ferraro
S. De Fazio
N. M. Marigliano
G. De Sarro
Publication date: 01-02-2007
Publisher: Springer International Publishing
Published in: Clinical Drug Investigation / Issue 2/2007
Print ISSN: 1173-2563
Electronic ISSN: 1179-1918
DOI: https://doi.org/10.2165/00044011-200727020-00004

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Retrospective Evaluation of Adverse Drug Reactions Induced by Nonsteroidal Anti-Inflammatory Drugs

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2007

Determining Factors in the Prescription of Moxifloxacin in Exacerbations of Chronic Bronchitis in the Primary-Care Setting

Monophasic Estrogen-Progestogen Therapy and Sexuality in Postmenopausal Women

Clinical Effectiveness of Quetiapine in Children and Adolescents with Tourette’s Syndrome

Comparative Cost-Benefit Analyses of Paricalcitol and Calcitriol in Stage 4 Chronic Kidney Disease from the Perspective of a Health Plan

Medical Costs of Chronic Musculoskeletal Pain in Italy

Cost Effectiveness of Imatinib Mesylate in the Treatment of Advanced Gastrointestinal Stromal Tumours